Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension

American Journal of Hypertension

Volumn 10, Issue 7 SUPPL. 1, 1997, Pages

  DeQuattro, Vincent ^a,b   Lee, Deping ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Clinical Sciences Building ^*  (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Blood pressure; Calcium antagonist; Monotherapy; Trandolapril; Verapamil

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; VERAPAMIL;

EID: 0030806222     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00102-7     Document Type: Article

References (23)

1. Frishman WH, Bryzinski BS, Coulson LR, et al: A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med 1994;154:1461-1468.
2. DeQuattro V: Benazepril compared with other antihypertensive agents, singly and in combination - a review, in Brunner HR, Salvetti A, Sever PS (eds):Benazepril: Profile of a New ACE Inhibitor. Royal Society of Medicine Services, Ltd., London, 1990.
3. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
4. Egashira K, Pipers FS, Rush J, Morgan JP: Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. J Am Coll Cardiol 1990;16:1296-1303.
5. Clozel M, Kuhn H, Fefti F: Effects of angiotensin converting enzyme inhibitors and of hydrazaline on endothelial function in hypertensive rats. Hypertension 1990;16:532-540.
6. Mancini GBJ, Henry GC, Macaya C, et al: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction Study). Circulation 1996; 94:258-265.
7. Rajagopalan S, Harrison DG: Reversing endothelial dysfunction with ACE inhibitors. A new TREND? Circulation 1996;94:240-243.
8. Weber KT, Sun Y: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994;23:869-877.
9. Asmar RG, Iannascoli F, Benetos A, Safar ME: Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension. J Hypertens 1992;10(5, suppl 7/92):S13-S19.
10. Bond MG, Strickland HL, Wilmoth SK, et al: Interventional clinical trials using noninvasive ultrasound end points: The Multicenter Isradipine/Diuretic Atherosclerosis Study. J Cardiovasc Pharm 1990;15(suppl 1):S30-S33.
11. McVeigh GE, Burns DE, Finkelstein SM, et al: Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens 1991;4:1-7.
12. O'Rourke M: Arterial mechanics and wave reflection with antihypertensive therapy. J Hypertens 1992; 10(suppl 5):S43-S49.
13. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertens 1992;5:95-110.
14. Kramer BL, Massie BM, Topic N: Controlled trial of captopril in CHF. Circulation 1983;4:807-816.
15. Petrella RJ, Nichol PM, Cunningham DA, et al: Verapamil improves left ventricular filling and exercise performance in hypertensive and normotensive elderly individuals. Can J Cardiol 1994; 10:973-981.
16. Kasiske B, Kalil R, Ma J, et al: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993;118:129-138.
17. Bakris G, Barnhill B, Sadler R: Treatment of arterial hypertension in diabetic humans. Importance of therapeutic selection. Kidney Int 1992;41:912-919.
18. DeQuattro V, Lee D, Messerli F, and The Trandolapril Study Group: Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: a 4 X 4 trial design. Clin Exp Hypertens 1997; 19(3):373-387.
19. Snappin SM: Evaluating the efficacy of a combination therapy. Stat Med 1987;6:657-665.
20. Saunders E, Weir MR, Kong W, et al: A comparison of the efficacy and safety of a β-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990;150:1707-1713.
21. Cesarone MR, de Santis MT, Laurora G, Belcaro G: Effect of trandolapril on 24-h ambulatory blood pressure in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 1994;23(suppl 4):S65-S71.
22. Jain AK, McMahon FG: 24-Hour blood pressure response to two slow-release verapamil formulations in patients with mild to moderate hypertension. Cardiovasc Rev Rep 1993;14(4):45-51.
23. DeQuattro V: Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists. Clin Exper Hypertens 1994;16(6):853-864.